Instituto de Bioquímica Médica, Programa de Biologia Molecular e Biotecnologia, Universidade Federal do Rio de Janeiro, CCS, Ilha do Fundão, Rio de Janeiro, Brasil.
PLoS One. 2012;7(6):e39104. doi: 10.1371/journal.pone.0039104. Epub 2012 Jun 18.
3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole (DIC) is a five-membered heterocyclic compound containing a N-O bond. The anti-inflammatory effects of this compound were studied both in vitro and in vivo.
DIC effectively decreased TNF-α and IL-6 release from LPS-stimulated macrophages in a dose dependent manner. DIC diminished the levels of COX-2 with subsequent inhibition of PGE(2) production. DIC also compromised HMGB1 translocation from the nucleus to the cytoplasm. Moreover, DIC prevented the nuclear translocation of NF-κB and inhibited the MAPK pathway. In vivo, DIC inhibited migration of neutrophils to the peritoneal cavity of mice.
This study presents the potential utilization of a synthetic compound, as a lead for the development of novel anti-inflammatory drugs.
3-(3-氯苯基)-5-(4-吡啶基)-4,5-二氢异恶唑(DIC)是一种含有 N-O 键的五元杂环化合物。该化合物的抗炎作用已在体外和体内进行了研究。
DIC 可有效降低 LPS 刺激的巨噬细胞中 TNF-α 和 IL-6 的释放,呈剂量依赖性。DIC 降低 COX-2 的水平,从而抑制 PGE(2)的产生。DIC 还可使 HMGB1 从核内易位至细胞质。此外,DIC 可阻止 NF-κB 的核易位并抑制 MAPK 途径。在体内,DIC 抑制了中性粒细胞向小鼠腹腔的迁移。
本研究提出了一种合成化合物的潜在应用,可作为开发新型抗炎药物的先导化合物。